Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion

China's First Oral COVID-19 Antiviral Medicine in Dispute

An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.

Trautec Medical Raises Nearly CNY 200 Mn in Series A Financing Round

Trautec Medical, dedicated to developing and producing recombinant collagen-based biomaterials, will continue to focus on the innovation of biomaterials and strive to integrate resources from all sides.

Preparation Developer Elite Pharmaceutical Nets Nearly CNY 100 Mn in Series B Round

This financing round will further promote the company's R&D and clinical trials and be used to construct new production bases. The completion of the new production base will significantly improve the application efficiency of the products independently developed by Elite and reduce the cost without reducing the capacity of the products.

Qiming-backed Biotech Insilico Medicine Completes Series D+ Financing Round

Insilico Medicine, the AI-powered biotech, aims to extend its services to all areas of life sciences with the newly added supporter from Saudi Arabia.

Aesthetic Medicine Company Tian Shi Wei Nets Tens of Millions of RMB in Series A Round

Soluble microneedle technology has received wide attention from the industry recently and is expected to be commercialized in aesthetic medicine. Tian Shi Wei gained capital preference for its R&D, mass production and quality control capabilities.